Generation of rabbit antibodies against death ligands by cDNA immunization

Journal of Immunological Methods

Volumn 317, Issue 1-2, 2006, Pages 12-20

  Diestre, C ^a   Martinez Lorenzo M J ^b   Bosque, A ^a   Naval, J ^a   Larrad, L ^b   Anel, A ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

AP03L TWEAK; Apo2L TRAIL; cDNA; FasL; Immunization; Polyclonal antibodies

Indexed keywords

COMPLEMENTARY DNA; FAS ANTIBODY; FAS LIGAND; GLYCOSYLATED PROTEIN; MEMBRANE PROTEIN; PROTEIN; PROTEIN ANTIBODY; PROTEIN TWEAK; RABBIT ANTISERUM; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; DNA, COMPLEMENTARY; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HELA CELLS; HUMANS; IMMUNOBLOTTING; JURKAT CELLS; RABBITS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR NECROSIS FACTORS; VACCINATION;

ORYCTOLAGUS CUNICULUS;

EID: 33751340827     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.08.018     Document Type: Article

References (33)

1. Anel A., Buferne M., Boyer C., Schmitt-Verhulst A.M., and Golstein P. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24 (1994) 2469
2. Ashkenazi A. Targeting death and decoy receptors of the TNF superfamily. Nat. Rev., Cancer 2 (2002) 420
3. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305
4. Berzofsky J.A., Ahlers J.D., and Belyakov I.M. Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1 (2001) 209
5. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.M., Scott H., Hession C., Garcia I., and Browning J.L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272 (1997) 32401
6. Chowdhury P.S., Gallo M., and Pastan I. Generation of high titer antisera in rabbits by DNA immunization. J. Immunol. Methods 249 (2001) 147
7. Dhein J., Walczak H., Bäumler C., Debatin K.M., and Krammer P.H. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373 (1995) 438
8. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189
9. Kieber-Emmons T., Monzavi-Karbassi B., Wang B., Luo P., and Weiner D.B. DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response. J. Immunol. 165 (2000) 623
10. -/- mice. Nat. Immunol. 4 (2003) 255
11. Martínez-Lorenzo M.J., Alava M.A., Anel A., Piñeiro A., and Naval J. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89 (1996) 511
12. Martínez-Lorenzo M.J., Alava M.A., Gamen S., Kim J.K., Chuntharapai A., Piñeiro A., Naval J., and Anel A. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28 (1998) 2714
13. Martínez-Lorenzo M.J., Anel A., Gamen S., Monleón I., Lasierra P., Larrad L., Piñeiro A., Alava M.A., and Naval J. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163 (1999) 1274
14. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991
15. Monleón I., Martínez-Lorenzo M.J., Anel A., Lasierra P., Larrad L., Piñeiro A., Naval J., and Alava M.A. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells. Eur. J. Immunol. 30 (2000) 1078
16. Monleón I., Martínez-Lorenzo M.J., Monteagudo L., Lasierra P., Taulés M., Iturralde M., Piñeiro A., Larrad L., Alava M.A., Naval J., and Anel A. Differential secretion of Fas ligand- or APO2 ligand/TRAIL-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167 (2001) 6736
17. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449
18. Nagata S., Salvatore G., and Pastan I. DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins. J. Immunol. Methods 280 (2003) 59
19. O'Connell J., O'Sullivan G.C., Collins J.K., and Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184 (1996) 1075
20. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., and Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271 (1996) 12687
21. Rieux-Laucat F., Le Deist F., and Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 10 (2003) 124
22. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177 (1993) 195
23. Smith D., Sieg S., and Kaplan D. Technical note: aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J. Immunol. 160 (1998) 4159
24. Smyth M.J., Cretney E., Takeda K., Wiltrout R.H., Sedger L.M., Kayagaki N., Yagita H., and Okumura K. TRAIL contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193 (2001) 661
25. Stokes T.A., Rymaszewski M., Arscott P.L., Wang S.H., Bretz J.D., Bartron J., and Baker Jr. J.R. Constitutive expression of FasL in thyrocytes. Science 279 (1998) 2015
26. Sträter J., Walczak H., Hasel C., Melzner I., Leithauser F., and Möller P. CD95 ligand immunohistochemistry: a critical study on 12 antibodies. Cell Death Differ. 8 (2001) 273
27. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., and Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76 (1994) 969
28. Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., and Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6 (1994) 1567
29. Tang D.C., DeVit M., and Johnston S.A. Genetic immunization is a simple method for eliciting and immune response. Nature 356 (1992) 152
30. Vignaux F., and Golstein P. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway?. Eur. J. Immunol. 24 (1994) 923
31. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314
32. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., and Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673
33. Wiley S.R., Cassiano L., Lofton T., Davis-Smith T., Winkies J.A., Lindner V., Liu H., Daniel T.O., Smith C.A., and Fanslow W.C. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15 (2001) 837